Literature DB >> 17574112

Pulmonary arterial hypertension in a patient with common variable immunodeficiency and unilateral bronchiectasis: Successful treatment with iloprost.

Z Daniil1, E Karetsi, E Zakynthinos, E Bakratsi, F Kalala, K I Gourgoulianis.   

Abstract

The present study describes a case of severe pulmonary arterial hypertension (PAH) associated with unilateral lung destruction due to bronchiectasis in a patient with common variable immunodeficiency (CVID). Initially, the patient's treatment included antibiotics, oral anticoagulants, diuretics, and immunoglobulin replacement therapy. However, the patient's condition improved significantly only after inhaled iloprost was administered. Three months later, his PAH was almost reversed. The hemodynamic response of our patient suggests that inhaled iloprost may have a role in the treatment of sustained PAH related to unilateral lung destruction.

Entities:  

Year:  2007        PMID: 17574112     DOI: 10.1016/j.ejim.2006.11.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  2 in total

1.  Clinical characteristics of pulmonary hypertension in bronchiectasis.

Authors:  Lan Wang; Sen Jiang; Jingyun Shi; Sugang Gong; Qinhua Zhao; Rong Jiang; Ping Yuan; Bigyan Pudasaini; Jing He; Zhicheng Jing; Jinming Liu
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

2.  Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency.

Authors:  Jessica Huston; Joyce Johnson; Anna Hemnes; Meredith Pugh
Journal:  Pulm Circ       Date:  2020-05-01       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.